CIK 0001781174 · <br>Emerging growth company
Acrivon Therapeutics, Inc.
Sign in to watch- Ticker
- ACRV
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 825125532
- Phone
- 617-207-8979
- Business address
- 480 ARSENAL WAY, SUITE 100, WATERTOWN, MA, 02472
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $38,534
- in 8 filings
Net −$38,534. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Blume-Jensen Peter −$34K President and CEO sold <1% of stake
- Miller Mary −$2K Chief Legal Officer sold 1% of stake
- Devroe Eric −$1K Chief Operating Officer sold <1% of stake
- Gamelin Erick −$804 Chief Development Officer sold <1% of stake
- Peterson Katharine −$203 Chief Accounting Officer sold <1% of stake
Reading 84 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-21 | Blume-Jensen Peter President and CEO | Shares withheld for taxes | −13,729 | $1.79 | $25K | 2,245,317 |
| 2026-05-18 | RA CAPITAL MANAGEMENT, L.P. Director | Grant or award | +9,366 | 9,366 | ||
| 2026-05-18 | TOMSICEK MICHAEL JOHN Director | Grant or award | +9,366 | 9,366 | ||
| 2026-05-18 | Shacham Sharon Director | Grant or award | +9,366 | 9,366 | ||
| 2026-05-18 | Palani Santhosh Director | Grant or award | +9,366 | 9,366 | ||
| 2026-05-18 | Magovcevic-Liebisch Ivana Director | Grant or award | +9,366 | 9,366 | ||
| 2026-05-18 | DiRocco Derek Director | Grant or award | +9,366 | 9,366 | ||
| 2026-05-18 | BAUM CHARLES M Director | Grant or award | +9,366 | 9,366 | ||
| 2026-05-18 | Peterson Katharine Chief Accounting Officer | Grant or award | +14,227 | 18,134 | ||
| 2026-05-18 | Mirza Mansoor Raza Chief Medical Officer | Grant or award | +38,817 | 38,817 | ||
| 2026-05-18 | Miller Mary Chief Legal Officer | Grant or award | +49,830 | 82,767 | ||
| 2026-05-18 | Levy Adam D. Chief Financial Officer | Grant or award | +46,167 | 67,150 | ||
| 2026-05-18 | Gamelin Erick Chief Development Officer | Grant or award | +38,584 | 52,992 | ||
| 2026-05-18 | Devroe Eric Chief Operating Officer | Grant or award | +72,981 | 146,953 | ||
| 2026-05-18 | Blume-Jensen Peter President and CEO | Grant or award | +180,095 | 2,259,046 | ||
| 2026-05-18 | Blume-Jensen Peter President and CEO | Grant or award | +72,706 | 386,343 | ||
| 2026-05-14 | Peterson Katharine Chief Accounting Officer | Shares withheld for taxes | −99 | $1.92 | $190 | 3,907 |
| 2026-05-14 | Miller Mary Chief Legal Officer | Shares withheld for taxes | −184 | $1.92 | $353 | 32,937 |
| 2026-05-14 | Gamelin Erick Chief Development Officer | Shares withheld for taxes | −404 | $1.92 | $776 | 14,408 |
| 2026-05-14 | Devroe Eric Chief Operating Officer | Shares withheld for taxes | −613 | $1.92 | $1K | 73,972 |
Page 2 of 6 · 113 trades